Survival in pulmonary arterial hypertension (PAH) and Eisenmenger syndrome (ES) relates to right ventricular (RV) function. Little is known about differences of ventricular function between ES patients and those suffering from other PAH aetiologies. In this study, we compared global ventricular function assessed by speckle-tracking in adult patients with ES, other PAH aetiologies, or healthy controls; and assessed the relationship between ventricular function and survival. 
Introduction
Pulmonary arterial hypertension (PAH) remains a devastating disease; patients are affected by symptoms and premature death both related to right ventricular (RV) dysfunction and inadequate adaptation. [1] [2] [3] [4] There are different PAH aetiologies. 5 Congenital heart disease is one of these aetiologies; Eisenmenger syndrome (ES) is the extreme end of this patient subgroup. Patients with ES seem to have a survival benefit compared with other PAH aetiologies. 6, 7 This is thought to be due to different RV adaptation to PAH in these patients, who are subject to volume and pressure overload from birth. 8, 9 The precise mechanism behind this different adaptive process is not well understood. Furthermore, we recently reported tricuspid annular plane systolic excursion (TAPSE), a marker of RV longitudinal function to be predictive of outcome in a cohort of adults with ES. There are no such prognostic data concerning global ventricular function. Strain imaging using speckle-tracking has been suggested as a better means of assessing RV function. 10 RV free wall peak longitudinal strain has previously been shown to relate to cardiovascular events and mortality in pulmonary hypertension. [11] [12] [13] [14] The aim of this study was therefore to assess global bi-ventricular function in patients with ES, PAH of other aetiologies, and healthy controls and to identify differences between the three groups and potential prognostic markers. Finally, we sought to study differences within the ES cohort, between patients with pre-tricuspid and posttricuspid shunt, where timing of onset of PAH and, thus, adaptation varies.
Methods

Study design and patients
We performed a prospective two-centre longitudinal study on PAH patients followed up at our centres (Royal Brompton Hospital, London, UK and Pasteur University Hospital, Nice, FR) between March 2011 and June 2015. The local research ethics committees approved this study. Clinically stable PAH patients were enrolled into a standardized echocardiographic protocol between March 2011 and March 2014. The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki. Consecutive adult PAH patients were recruited from the echocardiography department. If they consented to the study after appropriate information, they were included in the study. Pulmonary hypertension was diagnosed according to right heart catheterization data, when mean pulmonary artery pressure at rest was >25 mmHg and the pulmonary capillary wedge pressure was <15 mmHg. Patients with poor acoustic windows or complex congenital heart disease such as univentricular heart and systemic right ventricle were excluded from this study in order to standardize the echocardiographic analysis and facilitate the interpretation of echocardiographic parameters. Patients with significant left heart disease were also carefully excluded, especially those with diastolic dysfunction or significant left atrioventricular valve regurgitation. Demographic, clinical data (age, gender, diagnosis, associated genetic syndrome, NYHA class, heart rate, specific advanced therapy), brain natriuretic peptide (BNP) plasma levels [Beckman Access 2, Triage BNP assay (Biosite Diagnostics Inc., San Diego, CA, USA)], and 6 min walk test distance were also collected at baseline (time of echocardiography, qualifying the patient for inclusion). Follow-up was considered from the date of echocardiography and continued until patients either died or reached the end of the study (closure of follow-up was realized in June 2015) ( Figure 1) . Clinical outcome included mortality related to PAH.
Echocardiographic measurements
Echocardiographic examination was performed using an IE-33 ultrasound system (Philips Medical system, Andover, MA, USA). Doppler echocardiography was performed according to the recommendations of the American Society of Echocardiography. [15] [16] [17] Two different staff cardiologists with advanced training in echocardiography, blinded to other results and to each other, interpreted 2D-echo datasets. Three consecutive cycles were averaged for every parameter. Left atrial area, right atrial area, RV inlet, RV end-diastolic diameter, LV end-diastolic and end-systolic diameter were measured. Trans-mitral and trans-tricuspid pulsed-wave Doppler velocities were recorded from apical four-chamber view with Doppler sample placed between the tips of the valve leaflets. Early (E) and late (A) Doppler flow velocities of transmitral valve and trans-tricuspid valve (TV) were measured from mitral and tricuspid inflow profile and E/A ratio was calculated. The mitral and tricuspid annular peak systolic velocity (s 0 ), early and late diastolic velocities (e 0 and a 0 ) were obtained by placing a tissue Doppler sample volume at the lateral mitral and tricuspid annulus. Myocardial acceleration during isovolumic contraction was measured at the lateral tricuspid annulus using Tissue Doppler Imaging. 18 RV fractional area change was calculated from the four-chamber view. TAPSE was measured using M-mode from the tricuspid lateral annulus. The gradient between RV and right atrium was derived from the peak flow velocity of the tricuspid regurgitation (TR). RV outflow tract (RVOT) velocity-time integral (VTI) and pulmonary flow acceleration time were also measured at baseline. The pulmonary ejection time was measured from the onset to the cessation of pulsed-wave Doppler flow of the RVOT and indexed to the heart rate (ET/ͱRR). Durations of RV systole and diastole were measured from the clearest Doppler signal of tricuspid valve from the apical (most common) or parasternal view. Systolic duration was measured as duration (onset to termination) of TR. Diastolic duration was measured from termination of TR to onset of the subsequent TR tracing, 4 systolic/diastolic duration ratio (S/D ratio) being used as a marker of RV adaptation. Right atrial pressure was estimated on the basis of IVC diameter and collapse. 15 
RV and LV myocardial function
Right ventricular myocardial function was studied using speckle-tracking echocardiography of the apical long axis, obtained from the apical fourchamber view, during a quiet breath hold, with a frame rate of 60-80/s. Two consecutive heart cycles were recorded and averaged (excluding premature beats). The off-line analysis was performed using commercially available semi-automated 2D strain software: QLab 9.0 Cardiac Figure 1 Study flow chart. Mechanics Quantification (Philips Medical System, The Netherlands) for longitudinal strain analysis and Tomtec Cardiac Performance Analysis (TomTec Imaging Systems GmbH, Germany) for transverse strain analysis. The peak RV free wall longitudinal strain was defined as the peak negative value on the strain curve; peak RV free wall transverse strain was defined as the peak positive value on the strain curve before pulmonary valve closure. The RV cavity was traced manually delineating a region of interest composed by three segments of the lateral wall: basal, mid-cavity, and apical. After segmental tracking, the RV longitudinal (QLab) and transverse (TomTec) curves were generated and the average values of longitudinal and transverse strain were calculated. Left ventricular myocardial global longitudinal strain was assessed using speckle-tracking echocardiography of the apical long axis, obtained from the apical 4-; 3-, and 2-chamber views of the LV. LV circumferential strain was obtained by analysing the parasternal short axis of the LV mid-cavity.
Statistical analysis
Data were summarized as mean 6 SD for continuous variables and number of subjects (%) for categorical variables. Normally distributed variables were compared between groups using two-tailed Student's t-test for unpaired data. Variables that were not normally distributed were tested by the Mann-Whitney U test. Categorical variables were compared using Fisher's exact test. Multiple linear regression and analysis of covariance were performed to assess whether age had an effect on the relationship between CHD-PAH and the studied variables. The relation between echocardiographic parameters and death was assessed with the use of univariable and multivariable Cox proportional hazard regression analysis, using the date of echocardiography as start date. In addition, receiver operating characteristics curve was used to derive the best cut-off value to predict survival. Variability was assessed by intra-class correlation analysis; a good agreement being defined by an intra-class correlation coefficient >0. 80 . For all analyses, statistical significance was defined as P < 0.05. Statistical analyses were performed using MedCalc 14.12.0 (MedCalc Software, Mariakerke, Belgium).
Results
General characteristics of patient population
A total of 83 patients were included: 43 patients with ES and 40 patients with other PAH aetiologies. ES patients included 14 patients with a pre-tricuspid shunt (13 with an atrial septal defect and one with abnormal pulmonary venous return) and 29 with a posttricuspid defect (15 with ventricular septal defects, nine with complete atrioventricular septal defects, two with patent ductus arteriosus, two with common arterial trunk, and one with aortopulmonary window). Of the patients with other PAH aetiologies, 21 had idiopathic PAH, 18 had associated-PAH (10 patients with connective tissue disease, five patients with portal hypertension, and three patients with HIV infection) and one had drug-induced PAH. Thirty-seven healthy volunteers were also recruited to serve as controls for the speckle-tracking imaging analysis.
The demographic and clinical characteristics of the ES and other PAH aetiologies population are described in Table 1 . Most patients were in NYHA functional class III or IV at baseline and more than 70% of PAH patients were treated with PAH-targeted advanced therapies. Clinical characteristics were comparable between the two groups, with the exception of younger age for the ES patients.
Echocardiographic differences between ES, other aetiologies PAH, and healthy controls
There were significant differences in echocardiographic parameters between the two groups of PAH patients, even after adjusting for age ( Table 2) . The RV was more hypertrophied in ES, with higher RV systolic and lower right atrial pressures (indicating better RV diastolic function). RV function, as assessed by classic 2D/M-mode and Tissue Doppler Imaging parameters (TAPSE, TV S, myocardial acceleration during isovolumic contraction), was not different between the two groups, despite a trend towards a better RV fractional area change in ES patients. Although the Tei index was not statistically different in ES compared with other PAH aetiologies, RV adaptation assessed by means of the S/D ratio was significantly better, whereas pulmonary VTI was higher in ES. Furthermore, the left ventricle was less compressed, with a lower LV eccentricity index in ES.
Compared with healthy controls, all PAH patients presented with lower global LV and RV free wall longitudinal strain, and lower RV free wall transverse strain ( Table 3) . Most healthy controls presented a decreasing gradient in transverse strain from the base to the apex, this was present only in 19 .3% of PAH patients. The apical transverse strain was never predominant in healthy controls whereas this pattern was present in 44.2% of ES patients. Eisenmenger syndrome patients had similar levels of LV longitudinal and circumferential strain compared with other PAH patients. There is no difference in longitudinal RV free wall strain; however, ES patients presented higher RV free wall transverse strain, even after age-adjustment (26.1 6 17.1 vs. 14.2 6 11.5; P < 0.001) (Figure 2) . A higher proportion of ES patients had an important apical deformation with predominant apical transverse strain, compared with the midand basal RV free wall (P ¼ 0.004 vs. other PAH aetiologies; P < 0.001 vs. healthy controls).
No significant difference in LV or RV strain was observed between pre-tricuspid shunt patients and other PAH aetiologies (RV transverse strain, P ¼ 0.56; RV longitudinal strain, P ¼ 0.97; global LV longitudinal strain, P ¼ 0.66; LV circumferential strain, P ¼ 0.80).
In contrast, patients with post-tricuspid shunt had higher RV transverse strain (P < 0.0001) but similar degree of RV longitudinal strain (P ¼ 0.75) as compared with other PAH aetiologies patients. They also present more frequently an RV deformation pattern with predominant apical transverse strain (P ¼ 0.001). Global longitudinal LV strain was also reduced in post-tricuspid shunt patients in comparison with other PAH aetiologies (P ¼ 0.02) but no significant difference in LV circumferential strain was observed (P ¼ 0.13).
Differences between pre-and posttricuspid shunt in ES patients
Patients with ES related to a post-tricuspid shunt were compared with patients with pre-tricuspid shunts: in the former, the right ventricle was less dilated (44.2 6 4.7 vs. 49.3 6 9.2 mm; P ¼ 0.02) but more hypertrophied (12.6 6 2.8 vs. 10.4 6 3.7; P ¼ 0.01). Moreover, RV fractional area change and pulmonary VTI were higher in post-vs. pre-tricuspid shunts (42.7 6 8.9 vs. 33.3 6 10.8; P ¼ 0.03 and 20.1 6 6.8 vs. 14.0 6 4.4; P ¼ 0.003, respectively) whereas RV adaptation was better in pre-tricuspid shunts, with a lower S/D ratio (0.79 6 0.2 vs. 1.25 6 0.7; P ¼ 0.04). Post-tricuspid shunt patients had lower LV longitudinal strain but increased RV transverse strain (Table 4, Figure 3 ). There was no significant difference in RV free wall longitudinal strain between pre-and post-tricuspid shunts. 
Outcome analysis
Twenty-two PAH patients (26.5%) died from cardio-pulmonary causes at a median follow-up of 22.6 Transverse RV strain 22% identified patients at higher risk of mortality with a sensitivity of 95% and a specificity of 50% (HR 13.9, 95% CI: 1.9-104.2, P ¼ 0.01; area under curve 0.76; P < 0.001) (Figure 4) .
Reproducibility of speckle-tracking analysis
Intra-observer and inter-observer variability were assessed for left and right ventricular speckle-tracking analysis (longitudinal, circumferential, and transverse strain) in all patients and controls. All methods had a good intra-and inter-observer agreement, with intra-class (Table 5) . In a subset of 25 patients, including 10 healthy volunteers, intra-class correlation coefficient for RV apical transverse strain was optimal: 0.95 (0.89-0.97).
Discussion
We have shown hereby relative preservation of RV function in patients with ES compared with other PAH aetiologies. Indeed, ES patients had higher RV peak transverse strain and significant apical deformation, though no difference in RV longitudinal function as compared with other PAH. RV free wall peak transverse strain is an independent predictor of survival and may explain the survival advantage shown here in ES. In contrast, conventional RV function parameters were not different between ES and other PAH aetiologies patients suggesting that myocardial strain parameters may be better suited for assessing RV function in this setting.
Patients with ES clearly have a different cardiac remodelling 19 compared with other PAH patients, with increased RV wall and transverse strain which in turn seems to relate to outcome. Furthermore, RV longitudinal strain is reduced compared with healthy controls resembling patterns observed in patients with systemic RVs where a 'shift' from longitudinal to transverse RV function is evident. 20, 21 The systemic RV is exposed to systemic pressures from birth, as it is the case for patients with unrepaired non-restrictive ventricular septal defects. This pattern of deformation explains the similar TAPSE, TV s 0 , and the trend towards higher RV fractional area change related to increase transverse deformation. The RV wall is anatomically described as being composed of superficial fibres being arranged circumferentially, these fibres turning towards the cardiac apex, whereas deep RV muscle fibres are longitudinally arranged from the base to the apex. 22, 23 In the normal RV, the longitudinal deformation is the predominant one; 24 however, animal studies have shown heart exposed to RV pressure overload respond with RV wall hypertrophy and change in intra-myocardial fibre orientation. 25 Similarly, LV transverse and circumferential strain are increased in athletes but LV longitudinal strain is reduced. 26 Thus, we can hypothesize that chronic pressure overload from birth can produce a 'training effect' on the right ventricle, leading to different cardiac remodelling. Our study underlines the limitation of conventional RV function parameters, especially of TAPSE. Speckle-tracking imaging, avoiding the 'rocking motion' of the heart 27 overcomes this limitation. The role of regional RV longitudinal function has been previously investigated. The basal RV free wall plays a predominant role in patients with PAH, whereas no difference was found in longitudinal strain between apical and basal RV lateral walls in healthy controls. 28 We hereby also describe differences in regional transverse RV function: control patients having a base-to-apex decreasing gradient in transverse strain; 21 PAH patients losing this profile, whereas about 40% of ES patients present an increase in apical deformation as compared with basal RV. The role of apical function has been recently emphasized, 29 apical traction of the RV (the cardiac apex being pulled towards the LV) has been associated with outcomes in a retrospective study. Our data support this earlier observation, ES patients from our study with high transverse RV function and predominant apical function had better survival rates. Longitudinal shortening only represents 1D of RV myocardial deformation and transverse RV motion has a significantly stronger relationship with RV ejection fraction than longitudinal motion. 30 This is why we choose to analyse both longitudinal and transverse deformation that were reliably accessible from four-chamber views using speckle-tracking analysis. A recent study investigating children with RV obstruction demonstrated a shift from longitudinal to circumferential deformation in the RV free wall 31 justifying the RV analysis in more than 1D. RV free wall transverse strain has been previously correlated to exercise tolerance in PAH, it was predictive of outcome in our study, and patients with RV free wall peak transverse strain 22% had a 14-fold increased risk of death. Surprisingly, no difference in longitudinal strain was observed between ES and other patients. This might be related to the relatively old cohort of ES patients (mean age 41.4 6 15 years old) and the advanced disease in those patients (60.5% were NYHA functional class III or IV). Thus, we can hypothesize that RV longitudinal strain impairment might occur earlier than transverse strain decrease in PAH.
Within the ES cohort from our study, patients with post-tricuspid shunts had decreased LV longitudinal strain. Impaired LV function in post-tricuspid defects has been previously reported with classic parameters, 32 consistent with the hypothesis that in large ventricular septal defects the left and right ventricles function in unison both pumping into high resistance systemic and pulmonary circulations. RV longitudinal function in our study was no different between preand post-tricuspid shunt patients, whereas RV transverse strain was increased in post-tricuspid shunt patients. Our results also suggest that the myocardial deformation pattern of patients with pretricuspid shunts is intermediate but closer to the pattern observed in patients with other PAH aetiologies.
Study limitations
This was a prospective two-centre study recruiting PAH patients; more than half of them had ES. This may be seen as a selection bias. It reflects the designation of our units with a focus in congenital heart disease and enabled us to compare patients with ES vs. other PAH aetiologies, the aim of the study. Although a stratified analysis according to age was employed, the age differences between patients' groups were significant and accounted for differences in RV remodelling, e.g. in RV hypertrophy. Using 2D speckle-tracking analysis, we only assessed the RV lateral wall as seen in the four-chamber view although the heart deforms in 3D. Despite this spatial limitation, 2D-speckle-tracking of the RV correlated well with cardiac magnetic resonance data and was associated with clinical outcomes in PAH. Deformation imaging of the right heart occurs in 3D; however, circumferential strain was not assessed in our cohort due to technical limitations inherent to our adult population. 3D speckle-tracking imaging of the right ventricle will probably be the next step towards the comprehension of RV adaptation.
Dilated RVs seen in parasternal short-axis views in PAH patients may not fit into the acquisition field of the cardiac ultrasound probe whereas sub-costal short-axis views are limited in adults due to the imaging quality. Furthermore, the trabeculated myocardium of the RV makes the delineation of endocardial borders challenging although our intra-and inter-observer variability was very low both for peak longitudinal and transverse RV strain.
Conclusion
Cardiac remodelling differs between adults with ES and other PAH aetiologies. ES and increased RV free wall transverse strain were associated with better survival. Our data support speckle-tracking imaging for periodic assessment of patients with PAH.
